Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Brooks

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Clinical Respiratory Journal|February 15, 2012
Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPDEric Bateman, Gregory Feldman, Sally Kilbride, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 16, 2012
Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patientsJutta Beier, Jan van Noord, Amanda Deans, et al.
Health and Quality of Life Outcomes|November 16, 2013
Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary diseaseTeresa K Wilcox, Wen-Hung Chen, Kellee A Howard, et al.
The New England Journal of Medicine|April 19, 2018
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPDDavid A Lipson, Frank Barnhart, Noushin Brealey, et al.
The New England Journal of Medicine|April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic LeukodystrophyFrancesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Clinical Respiratory Journal|February 15, 2012
Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPDEric Bateman, Gregory Feldman, Sally Kilbride, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 16, 2012
Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patientsJutta Beier, Jan van Noord, Amanda Deans, et al.
Health and Quality of Life Outcomes|November 16, 2013
Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary diseaseTeresa K Wilcox, Wen-Hung Chen, Kellee A Howard, et al.
The New England Journal of Medicine|April 19, 2018
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPDDavid A Lipson, Frank Barnhart, Noushin Brealey, et al.
The New England Journal of Medicine|April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic LeukodystrophyFrancesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Pageof 2